Marstacimab (Anti-TFPI)

Synonyms: PF-06741086

Marstacimab (Anti-TFPI) is a monoclonal antibody targeting tissue factor pathway inhibitor (TFPI). It can be used for the research of hemophilia. MW :142.94 KD.

Marstacimab (Anti-TFPI)

Purity & Quality Control

Biological Activity

Description Marstacimab (Anti-TFPI) is a monoclonal antibody targeting tissue factor pathway inhibitor (TFPI). It can be used for the research of hemophilia. MW :142.94 KD.

Product Details

CAS No. 1985638-39-8
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Marstacimab (Anti-TFPI) | Marstacimab (Anti-TFPI) supplier | purchase Marstacimab (Anti-TFPI) | Marstacimab (Anti-TFPI) cost | Marstacimab (Anti-TFPI) manufacturer | order Marstacimab (Anti-TFPI) | Marstacimab (Anti-TFPI) distributor